MM cells engineered to express granulocyte-macrophage colony-stimulating factor (GM-CSF) such as GVAX recruits antigen presenting cells more effectively and represents an attractive modality for further study [211]. This evidence concerns the gene CSF2 and Miyoshi myopathy.